Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUCOLASE in acute upper respiratory infection or acute bronchitis
NCT04252963Phase 4Unknown
- Sponsor
- Hanmi Pharmaceutical
- Start
- Nov 2018
- Primary completion
- Feb 2021
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of streptokinase + streptodornase in acute upper respiratory infection (URI), acute bronchitis, sponsored by Hanmi Pharmaceutical. Status: unknown.
02
Drugs
streptokinase + streptodornase
03
Conditions
acute upper respiratory infection (URI)acute bronchitis
Beyond the preview
Go deeper on NCT04252963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252963.